Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 37,652 shares at $86.06 ($3.2M) on 2017-09-27, disclosed to the SEC on 2017-09-28.
Open-market sale of $3.2M MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.31 | 18,526 | $1.6M | 49.2% |
| 2 | $85.31 | 18,526 | $1.6M | 49.2% |
| 3 | $86.06 | 600 | $52K | 1.6% |
| Total | $85.32 avg | 37,652 | $3.2M | 100% |
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |